home / stock / mrvi / mrvi news


MRVI News and Press, Maravai LifeSciences Holdings Inc. From 11/07/23

Stock Information

Company Name: Maravai LifeSciences Holdings Inc.
Stock Symbol: MRVI
Market: NASDAQ
Website: maravai.com

Menu

MRVI MRVI Quote MRVI Short MRVI News MRVI Articles MRVI Message Board
Get MRVI Alerts

News, Short Squeeze, Breakout and More Instantly...

MRVI - Maravai LifeSciences Reports Third Quarter 2023 Financial Results

Announces Realignment to Drive Operational Efficiencies and Streamline the Business Post-Pandemic Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai...

MRVI - Expected US Company Earnings on Tuesday, November 7th, 2023

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...

MRVI - Expected earnings - Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc. (MRVI) is expected to report $-0.03 for Q3 2023

MRVI - TriLink BioTechnologies® Expands Capabilities with Launch of 'Analytical Sciences Center of Excellence'

Centralized hub for advanced testing of nucleic acids to simplify mRNA drug substance testing, accelerating critical therapeutic development TriLink BioTechnologies ® (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and s...

MRVI - Maravai LifeSciences: Falling Victim To COVID Boom And Bust

2023-10-28 07:21:15 ET Summary Maravai LifeSciences raised $1.62bn in its IPO on Nasdaq in November 2020. Maravai acquired TriLink BioTechnologies in 2016 and developed the CleanCap analog technology used in COVID vaccines. This was a highly lucrative product in 2021 and 2022,...

MRVI - Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023

SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2023 financial and operating results after the market closes on ...

MRVI - Maravai LifeSciences Hosts 2023 Investor R&D Day

SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, hosted its 2023 Investor R&D Day featuring ...

MRVI - Catalyst Watch: Meta Platforms talks AI, Nike earnings and Huawei chip drama

2023-09-22 15:00:17 ET More on the markets No Signs Of A Major Top Yet, Staying Long BofA strategists have changed their view of the S&P 500 target, up 4%. Quant stock news sentiment measure keeps improving - BofA Amazon, Disney, Boeing boosted in Wells F...

MRVI - Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100

SAN DIEGO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Chief Innovation Officer Kate Broderick, PhD, has been named to the 2023 PharmaVoice 100 lis...

MRVI - Maravai LifeSciences to Host 2023 Investor R&D Day

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that it will host its 2023 Investor R&D Day on Thursday, September 28, start...

Previous 10 Next 10